Third Rock Ventures
Biotech Investor · 8 portfolio companies
Portfolio
8
Combined Value
$11.1B
Focus Areas
18
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Tango Therapeutics | $2.8B |
| Beam Therapeutics | $2.5B |
| Maze Therapeutics | $2.3B |
| Relay Therapeutics | $1.8B |
| Rapport Therapeutics | $1.3B |
| Third Harmonic Bio | $240M |
| CARGO Therapeutics | $210M |
| ARTBIO | — |